0001615774-18-006729.txt : 20180720
0001615774-18-006729.hdr.sgml : 20180720
20180720165019
ACCESSION NUMBER: 0001615774-18-006729
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180720
FILED AS OF DATE: 20180720
DATE AS OF CHANGE: 20180720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Opportunity Fund, L.P.
CENTRAL INDEX KEY: 0001726403
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 18962923
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650-688-0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Opportunity, LLC
CENTRAL INDEX KEY: 0001728970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 18962924
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE
STREET 2: SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 6506880818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE
STREET 2: SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital Surplus Fund VIII, L.P.
CENTRAL INDEX KEY: 0001628048
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 18962925
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital Fund VIII, L.P.
CENTRAL INDEX KEY: 0001618788
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 18962926
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital, LLC
CENTRAL INDEX KEY: 0001674712
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 18962927
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650-688-0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital VIII, LLC
CENTRAL INDEX KEY: 0001618789
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 18962928
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0822
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6197 CORNERSTONE COURT, SUITE 111
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 6197 CORNERSTONE COURT, SUITE 111
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
s111487_form4.xml
4
X0306
4
2018-07-20
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001618789
Vivo Capital VIII, LLC
C/O VIVO CAPITAL LLC
505 HAMILTON AVENUE, SUITE 207
PALO ALTO
CA
94301
0
0
1
0
0001674712
Vivo Capital, LLC
505 HAMILTON AVENUE, SUITE 207
PALO ALTO
CA
94301
0
0
1
0
0001618788
Vivo Capital Fund VIII, L.P.
505 HAMILTON AVENUE, SUITE 207
PALO ALTO
CA
94301
0
0
1
0
0001628048
Vivo Capital Surplus Fund VIII, L.P.
505 HAMILTON AVENUE, SUITE 207
PALO ALTO
CA
94301
0
0
1
0
0001728970
Vivo Opportunity, LLC
505 HAMILTON AVENUE, SUITE 207
PALO ALTO
CA
94301
0
0
1
0
0001726403
Vivo Opportunity Fund, L.P.
505 HAMILTON AVENUE, SUITE 207
PALO ALTO
CA
94301
0
0
1
0
Common Stock
2018-07-20
4
C
0
2560613
A
2560613
I
See Footnote
Common Stock
2018-07-20
4
C
0
353590
A
353590
I
See Footnote
Common Stock
2018-07-20
4
C
0
413040
A
2973653
I
See Footnote
Common Stock
2018-07-20
4
C
0
57035
A
410625
I
See Footnote
Common Stock
2018-07-20
4
P
0
51686
17.00
A
3025339
I
See Footnote
Common Stock
2018-07-20
4
P
0
7137
17.00
A
417762
I
See Footnote
Common Stock
2018-07-20
4
P
0
141177
17.00
A
141177
I
See Footnote
Common Stock
2018-07-20
4
P
0
153180
20.73
A
294357
I
See Footnote
Series A Preferred Stock
2018-07-20
4
C
0
8424416
D
Common Stock
2560613
0
I
See Footnote
Series A Preferred Stock
2018-07-20
4
C
0
1163311
D
Common Stock
353590
0
I
See Footnote
Series B Preferred Stock
2018-07-20
4
C
0
1358903
D
Common Stock
413040
0
I
See Footnote
Series B Preferred Stock
2018-07-20
4
C
0
187648
D
Common Stock
57035
0
I
See Footnote
The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 3.29 to 1 share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date.
These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF").
These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF").
These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF").
Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. Vivo Capital LLC is the management company of Vivo LLC. The voting members of each of Vivo Capital LLC and Vivo LLC are Frank Kung, Albert Cha, Edgar Engleman, Chen Yu and Shan Fu, none of whom has individual voting or investment power with respect to these securities. Jack B. Nielsen, M.Sc., a director of the Issuer, is a Managing Director at Vivo Capital LLC. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes.
Vivo Opportunity, LLC is the general partner of VOF. Vivo Capital LLC is the management company of Vivo Opportunity, LLC. The voting members of Vivo Opportunity, LLC are Frank Kung, Albert Cha, Shan Fu, Gaurav Aggarwal and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes.
The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $24.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4.
/s/ Albert Cha as managing member of Vivo Capital VIII, LLC
2018-07-20
/s/ Albert Cha as managing member of Vivo Capital LLC
2018-07-20
/s/ Albert Cha as a managing member of Vivo Capital VIII, LLC, the general partner of Vivo Capital Fund VIII, L.P.
2018-07-20
/s/ Albert Cha as a managing member of Vivo Capital VIII, LLC, the general partner of Vivo Capital Surplus Fund VIII, L.P.
2018-07-20
/s/ Albert Cha as a managing member of Vivo Opportunity, LLC
2018-07-20
/s/ Albert Cha as a managing member of Vivo Opportunity, LLC, the general partner of Vivo Opportunity Fund, L.P.
2018-07-20